Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness and safety of different doses of
Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood
(dyslipidemia).